文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

YY1通过miR-130a-3p/TREM-2轴促进小胶质细胞M2极化以减轻脓毒症相关脑病

YY1 PROMOTES MICROGLIA M2 POLARIZATION THROUGH THE MIR-130A-3P/TREM-2 AXIS TO ALLEVIATE SEPSIS-ASSOCIATED ENCEPHALOPATHY.
PubMed 文献 · Shock · 2022-01-01
一句话结论细胞与动物实验显示YY1通过抑制miR-130a-3p、上调TREM-2促进小胶质细胞M2极化,减轻脓毒症相关脑病的神经炎症与行为缺陷,作者认为YY1过表达可能是新型治疗策略。

研究用脂多糖(LPS)处理构建脓毒症相关脑病(SAE)细胞模型、盲肠结扎穿孔术构建SAE动物模型,检测YY1、miR-130a-3p与TREM-2的表达及认知功能、小胶质细胞极化状态。结果发现SAE中YY1与TREM-2下调、miR-130a-3p上调;YY1过表达可在体外和体内促进小胶质细胞M2极化、减轻神经炎症与行为缺陷。机制上YY1抑制miR-130a-3p启动子活性,TREM-2为miR-130a-3p的靶点;作者据此认为YY1过表达可能是SAE的新型治疗策略。

要点

  • SAE细胞模型(LPS处理)与动物模型(盲肠结扎穿孔术)中YY1和TREM-2表达下调、miR-130a-3p上调。
  • YY1过表达可在体外和体内促进小胶质细胞M2极化,并减轻神经炎症与行为缺陷。
  • YY1可抑制miR-130a-3p启动子活性;miR-130a-3p过表达可消除YY1过表达对LPS处理BV-2细胞的作用。
  • TREM-2被鉴定为miR-130a-3p的靶点;沉默TREM-2可逆转抑制miR-130a-3p对LPS处理BV-2细胞的作用。
  • 作者认为YY1过表达可能是SAE的新型治疗策略,尚属机制层面的实验发现。

适用人群与场景

  • 脓毒症相关脑病(SAE)的细胞模型(LPS处理的BV-2小胶质细胞)与动物模型(盲肠结扎穿孔术)

研究设计与关键结果

  • 研究类型为细胞与动物实验:SAE细胞模型由LPS处理构建,SAE动物模型由盲肠结扎穿孔术构建。
  • SAE中YY1和TREM-2表达下调、miR-130a-3p上调。
  • YY1过表达促进小胶质细胞M2极化,并在体外和体内减轻神经炎症与行为缺陷。
  • YY1可抑制miR-130a-3p启动子活性;miR-130a-3p过表达可消除YY1过表达对LPS处理BV-2细胞的作用。
  • TREM-2被鉴定为miR-130a-3p的靶点;沉默TREM-2可逆转抑制miR-130a-3p对LPS处理BV-2细胞的作用。
  • 结合关系由双荧光素酶报告基因实验和/或染色质免疫沉淀(ChIP)实验验证。

证据类型、等级与局限

  • 证据类型:细胞与动物实验(基础研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为YY1过表达可能是SAE的新型治疗策略;该结论来自LPS处理BV-2细胞与盲肠结扎穿孔术动物模型的机制实验。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Purpose: Sepsis-associated encephalopathy (SAE) induces cognitive dysfunction via mechanisms that commonly involve neuroinflammation. Yin Yang 1 (YY1) is an important transcription factor that acts as a key role in sepsis and neuroepithelium development. However, the function of YY1 in SAE remains unclear. Our study aimed to probe the intrinsic and concrete molecular mechanism of YY1 in SAE. Methods: SAE cell model and SAE animal model were constructed by lipopolysaccharide (LPS) treatment and cecal ligation and puncture surgery, respectively. Behavioral tests were performed to analyze the cognitive function. The polarization state of mouse microglia (BV-2 cells) was assessed by flow cytometry assay. The mRNA and protein expressions were assessed by qRT-PCR and western blot. Finally, the binding relationships between YY1, miR-130a-3p, andTREM-2were verified by dual luciferase reporter gene assay and/or ChIP assay. Results: Here our results described that YY1 and TREM-2 were downregulated and miR-130a-3p was upregulated in SAE. YY1 overexpression could promote M2 polarization of microglia, and alleviate neuroinflammation and behavioral deficits in vitro and in vivo. YY1 could inhibit miR-130a-3p promoter activity. As expected, miR-130a-3p overexpression abolished the effects of YY1 overexpression on LPS-treated BV-2 cells. Besides, TREM-2 was identified as the target of miR-130a-3p. TREM-2 silencing could reverse the effects of miR-130a-3p inhibition on LPS-treated BV-2 cells. Conclusion: Taken together, YY1 promoted microglia M2 polarization via upregulating TREM-2 by interacting with miR-130a-3p promoter, suggesting YY1 overexpression might be a novel therapeutic strategy of SAE.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Peng LS, Xu Y, Wang QS, et al. YY1 PROMOTES MICROGLIA M2 POLARIZATION THROUGH THE MIR-130A-3P/TREM-2 AXIS TO ALLEVIATE SEPSIS-ASSOCIATED ENCEPHALOPATHY. Shock. 2022. PMID: 35234205. doi:10.1097/SHK.0000000000001914

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。